Cargando…

Effectiveness of continuous venovenous hemodiafiltration using a polymethylmethacrylate membrane hemofilter in septic shock patients

Detalles Bibliográficos
Autores principales:	Sakamoto, Y, Mashiko, K, Obata, T, Matsumoto, H, Yamamoto, Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088828/ http://dx.doi.org/10.1186/cc6678

Ejemplares similares

Effectiveness of continuous venovenous hemodiafiltration using a polymethylmethacrylate membrane hemofilter judging from a multiplex suspension array system in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2011)

Role of early continuous venovenous hemodiafiltration in septic shock and multiorgan failure
por: Soliman, M, et al.
Publicado: (2010)

Pharmacokinetics of daptomycin in patients undergoing low-flow continuous venovenous hemodiafiltration
por: Ide, TI, et al.
Publicado: (2015)

Pharmacokinetics and pharmacodynamics of esomeprazole and ranitidine during continuous venovenous hemodiafiltration
por: Fuhrmann, V, et al.
Publicado: (2013)

Systemic hemodynamic during continuous hemodiafiltration in patients with septic shock
por: Mouravev, O, et al.
Publicado: (2004)

Dynamics of the dosage of citrate-calciuminfusion regimens as anticoagulation in continuous venovenous hemodiafiltration
por: Marin Mateos, H, et al.
Publicado: (2015)

Control of intra-abdominal pressure in severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter and colloid fluid therapy
por: Matsuda, K, et al.
Publicado: (2005)

Plasmatic cytokines and intermittent hemodialysis with polymethylmethacrylate membrane in septic shock patients
por: Mayeur, N, et al.
Publicado: (2009)

Mechanism and effectiveness of polymyxin B-immobilized fiber columns for removing mediators (HMBG-1, 2-arachidonoyl glycerol, anandamide, PAI-1, protein C and IL-6) in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2007)

Lipid mediator adosorption with dialyser membrane in patients with septic shock
por: Kase, Y, et al.
Publicado: (2009)

Selection of acute blood purification therapy according to lipid mediator adsorption and blood purification in patients with septic shock
por: Sakamoto, Y, et al.
Publicado: (2010)

Increase in systolic blood pressure and improvement in laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock
por: Sakamoto, Y, et al.
Publicado: (2010)

Continuous venovenous hemodiafiltration using cytokine-adsorbing hemofilters as adjuvant therapy for anaerobic descending necrotizing mediastinitis: a case report
por: Popevski, Dijana, et al.
Publicado: (2019)

Comparison of the efficacy between continuoushemodiafiltration with polymethylmethacrylate (PMMA) membrane hemofilter CH-1.8W(®) and with pmma membrane dialyzer BK-2.1P(®) in the treatment of critically ill patients
por: Harada, D, et al.
Publicado: (2015)

Amino acid concentrations in serum, urine and dialysate/ultrafiltrate solutions of continuous venovenous hemodiafiltration patients
por: Lee, JM, et al.
Publicado: (2012)

Impedance cardiography in the estimation of hemodynamic and fluid status of coma patients during continuous venovenous hemodiafiltration
por: De Nicola, A, et al.
Publicado: (2009)

Pilot study on a regional citrate anticoagulated continuous venovenous hemodiafiltration protocol with variable treatment dose
por: Slowinski, T, et al.
Publicado: (2010)

Blood epuration of middle molecules in continuous venovenous hemodiafiltration with regional citrate anticoagulation versus systemic heparinization
por: Nogier, MB, et al.
Publicado: (2009)

Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2006)

Does early appropriate antibiotic therapy improve the outcome of severe sepsis or septic shock?
por: Saito, N, et al.
Publicado: (2009)

The effect of polymixin B immobilized on fibers and continuous veno-venous hemodiafiltration on tetrahydrobiopterine and NO metabolites in septic patients
por: Kakihana, Y, et al.
Publicado: (2006)

A simple predictive scoring system for prolonged mechanical ventilation in severe sepsis and septic shock
por: Saito, N, et al.
Publicado: (2010)

Best choice of acute blood purification therapy based on the severity score and blood lactic acid values in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2009)

Relationship between the use of polymyxin B-immobilized fiber for hemofiltration and some laboratory parameters (endocannabinoids, high mobility group box-1 protein and oxidative stress) in severe pneumonia patients
por: Mashiko, K, et al.
Publicado: (2008)

Continuous venovenous haemofiltration in neonates
por: Mayell, S, et al.
Publicado: (2004)

Comparison of Sustained Hemodiafiltration with Acetate-Free Dialysate and Continuous Venovenous Hemodiafiltration for the Treatment of Critically Ill Patients with Acute Kidney Injury
por: Abe, Masanori, et al.
Publicado: (2011)

Cefiderocol Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemodiafiltration
por: Kobic, Emir, et al.
Publicado: (2021)

Continuous hemodiafiltration for hypercytokinemia in tumor lysis syndrome
por: Nakamura, M, et al.
Publicado: (2005)

Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
por: Lenga, Ilan, et al.
Publicado: (2019)

New Frontiers in Sepsis-Induced Acute Kidney Injury and Blood Purification Therapies: The Role of Polymethylmethacrylate Membrane Hemofilter
por: Stasi, Alessandra, et al.
Publicado: (2023)

Beneficial effects of early hemoperfusion with a polymyxin B fibre column on septic shock
por: Takeyama, N, et al.
Publicado: (2009)

Clearance of Sotalol on continuous venovenous haemofiltration
por: Roberts, H, et al.
Publicado: (2005)

Removing endocannabinoids and reducing oxidative stress with polymyxin-B-immobilized fibers in patients with septic shock
por: Kase, Y, et al.
Publicado: (2007)

Pharmacokinetics of gentamicin and vancomycin during continuous venovenous hemofiltration in critically ill septic patients with acute kidney injury
por: Petejova, N, et al.
Publicado: (2013)

Variability in Uremic Control during Continuous Venovenous Hemodiafiltration in Trauma Patients
por: Beitland, Sigrid, et al.
Publicado: (2012)

Near-infrared spectroscopy parameters in patients undergoing continuous venovenous hemodiafiltration
por: Chaves, Renato Carneiro de Freitas, et al.
Publicado: (2019)

Effect of Phoxilium on prognostic predictors in patients undergoing continuous venovenous hemodiafiltration
por: Kim, Da Woon, et al.
Publicado: (2021)

Characteristics of continuous venovenous hemodiafiltration in the acute treatment of inherited metabolic disorders
por: Eminoğlu, Fatma Tuba, et al.
Publicado: (2021)

Elimination of linezolid in patients undergoing low-flow continuous venovenous haemodiafiltration
por: Ide, T, et al.
Publicado: (2012)

Clinical efficacy of blood purification using a polymethylmethacrylate hemofilter for the treatment of severe acute pancreatitis
por: Kinjoh, Kiyohiko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1e6ohoqggeoppfsv5mehcacvfe